对经历肝肠循环的药物的曲线下面积测量值的解读。 - Suppr

Suppr

超能文献

Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.

作者信息

Shepard T A, Reuning R H, Aarons L J

出版信息

J Pharm Sci. 1985 Feb;74(2):227-8. doi: 10.1002/jps.2600740228.

DOI:10.1002/jps.2600740228

PMID:3989699

Abstract

摘要

相似文献

Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.对经历肝肠循环的药物的曲线下面积测量值的解读。

J Pharm Sci. 1985 Feb;74(2):227-8. doi: 10.1002/jps.2600740228.

Estimation of area under the curve for drugs subject to enterohepatic cycling.对经历肠肝循环的药物的曲线下面积的估算。

J Pharmacokinet Biopharm. 1985 Dec;13(6):589-608. doi: 10.1007/BF01058903.

Effect modelling for drugs undergoing enterohepatic circulation.进行肠肝循环的药物的效应建模。

Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):333-8. doi: 10.1007/BF03190182.

Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study.经历肠肝循环药物的蓄积及达到稳态的时间：一项刺激研究

J Pharm Sci. 1985 Dec;74(12):1331-3. doi: 10.1002/jps.2600741216.

Mean residence time for drugs subject to enterohepatic cycling.经历肠肝循环的药物的平均驻留时间。

J Pharmacokinet Biopharm. 1989 Jun;17(3):327-45. doi: 10.1007/BF01061900.

Drug disposition and liver disease.药物处置与肝脏疾病

Drug Metab Rev. 1975;4(2):139-75. doi: 10.3109/03602537508993754.

Drug recirculation model with multiple cycles occurring at unequal time intervals.具有在不等时间间隔发生多个循环的药物再循环模型。

J Biomed Eng. 1992 Nov;14(6):521-6. doi: 10.1016/0141-5425(92)90107-v.

Segmentally continuous input functions in linear multicompartment systems.

J Pharm Sci. 1985 Feb;74(2):136-41. doi: 10.1002/jps.2600740207.

Clearance and biologic half-life as indices of intrinsic hepatic metabolism.清除率和生物半衰期作为肝脏内在代谢的指标。

J Pharmacol Exp Ther. 1974 Oct;191(1):17-24.

Pharmacokinetics of drugs subject to enterohepatic circulation.具有肠肝循环的药物的药代动力学。

J Pharm Sci. 1979 Jun;68(6):792-4. doi: 10.1002/jps.2600680634.

引用本文的文献

Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.肠肝循环药物的药代动力学模拟及曲线下面积估计

Pharmaceutics. 2024 Aug 6;16(8):1044. doi: 10.3390/pharmaceutics16081044.

Enteric reabsorption processes and their impact on drug pharmacokinetics.肠内重吸收过程及其对药物药代动力学的影响。

Sci Rep. 2021 Mar 11;11(1):5794. doi: 10.1038/s41598-021-85174-w.

A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.一种用于药代动力学研究的基于胆囊的肠肝循环模型。

Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):493-504. doi: 10.1007/s13318-018-0535-1.

Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.肠肝循环：生理、药代动力学及临床意义。

Clin Pharmacokinet. 2002;41(10):751-90. doi: 10.2165/00003088-200241100-00005.

Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.吗啡在人体内的药代动力学与代谢。肠肝循环及代谢产物对活性阿片类药物浓度的相对贡献。

Clin Pharmacokinet. 1993 Apr;24(4):344-54. doi: 10.2165/00003088-199324040-00007.

Estimation of area under the curve for drugs subject to enterohepatic cycling.对经历肠肝循环的药物的曲线下面积的估算。

J Pharmacokinet Biopharm. 1985 Dec;13(6):589-608. doi: 10.1007/BF01058903.

An equation for the systemic availability of drugs undergoing simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination.一个用于描述同时经历肠肝循环、首过代谢和肠道消除的药物的全身可用性的方程。

Pharm Res. 1987 Jun;4(3):195-9. doi: 10.1023/a:1016447826075.

Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.通过高压液相色谱法测定依托红霉素相对于琥乙红霉素的药代动力学优势。

Antimicrob Agents Chemother. 1988 Apr;32(4):561-5. doi: 10.1128/AAC.32.4.561.

Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

J Pharmacokinet Biopharm. 1988 Aug;16(4):413-72. doi: 10.1007/BF01062554.

Mean residence time for drugs subject to enterohepatic cycling.经历肠肝循环的药物的平均驻留时间。

J Pharmacokinet Biopharm. 1989 Jun;17(3):327-45. doi: 10.1007/BF01061900.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验